During the past decade, Global Medical Institutes, LLC conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 9 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 6 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Global Medical Institutes, LLC" #1 sponsor was "Naurex, Inc, an affiliate of Allergan plc" with 4 trials, followed by "ACADIA Pharmaceuticals Inc." with 2 trials sponsored, "Athira Pharma" with 2 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Epix Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Global Medical Institutes, LLC" #1 collaborator was "National Institute on Aging (NIA)" with 2 trials as a collaborator, "Alzheimer's Disease Cooperative Study (ADCS)" with 1 trials as a collaborator, "Clinartis" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Global Medical Institutes, LLC" are "Alzheimer's Disease" (10 trials), "Alzheimer Disease" (7 trials), "Depressive Disorder, Major" (4 trials), "Major Depressive Disorder" (3 trials) and "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials). Many other conditions were trialed in "Global Medical Institutes, LLC" in a lesser frequency.

Most popular intervention types in "Global Medical Institutes, LLC" are "Drug" (38 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Rapastinel" (3 trials), "ATH-1017" (2 trials), "AVP-786" (2 trials) and "Donepezil" (2 trials). Other intervention names were less common.

The vast majority of trials in "Global Medical Institutes, LLC" are 39 trials for "All" genders.

Currently, there are NaN active trials in "Global Medical Institutes, LLC". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 23 completed trials in Global Medical Institutes, LLC, 1 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Global Medical Institutes, LLC, 3 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".